Literature DB >> 24617921

Bacterial self-defence: how Escherichia coli evades serum killing.

Helen Miajlovic1, Stephen G Smith.   

Abstract

The ability to survive the bactericidal action of serum is advantageous to extraintestinal pathogenic Escherichia coli that gain access to the bloodstream. Evasion of the innate defences present in serum, including complement and antimicrobial peptides, involves multiple factors. Serum resistance mechanisms utilized by E. coli include the production of protective extracellular polysaccharide capsules and expression of factors that inhibit or interfere with the complement cascade. Recent studies have also highlighted the importance of structural integrity of the cell envelope in serum survival. These survival strategies are outlined in this review with particular attention to novel findings and recent insights into well-established resistance mechanisms.
© 2014 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  capsule; colanic acid; complement; envelope stress regulators; lipopolysaccharide; outer membrane proteins

Mesh:

Year:  2014        PMID: 24617921     DOI: 10.1111/1574-6968.12419

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  47 in total

1.  Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement.

Authors:  Marta Putrinš; Karin Kogermann; Eliisa Lukk; Markus Lippus; Vallo Varik; Tanel Tenson
Journal:  Infect Immun       Date:  2015-01-05       Impact factor: 3.441

2.  Blocking yersiniabactin import attenuates extraintestinal pathogenic Escherichia coli in cystitis and pyelonephritis and represents a novel target to prevent urinary tract infection.

Authors:  Ariel R Brumbaugh; Sara N Smith; Sargurunathan Subashchandrabose; Stephanie D Himpsl; Tracy H Hazen; David A Rasko; Harry L T Mobley
Journal:  Infect Immun       Date:  2015-01-26       Impact factor: 3.441

3.  Defining the Mechanical Determinants of Kingella kingae Adherence to Host Cells.

Authors:  Brad K Kern; Eric A Porsch; Joseph W St Geme
Journal:  J Bacteriol       Date:  2017-10-31       Impact factor: 3.490

4.  The Mla Pathway Plays an Essential Role in the Intrinsic Resistance of Burkholderia cepacia Complex Species to Antimicrobials and Host Innate Components.

Authors:  Steve P Bernier; Susie Son; Michael G Surette
Journal:  J Bacteriol       Date:  2018-08-24       Impact factor: 3.490

Review 5.  Antibody-Dependent Enhancement of Bacterial Disease: Prevalence, Mechanisms, and Treatment.

Authors:  Von Vergel L Torres; Carrie F Coggon; Timothy J Wells
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

6.  Genotoxic Escherichia coli Strains Encoding Colibactin, Cytolethal Distending Toxin, and Cytotoxic Necrotizing Factor in Laboratory Rats.

Authors:  Susanna A Kurnick; Anthony J Mannion; Yan Feng; Carolyn M Madden; Paul Chamberlain; James G Fox
Journal:  Comp Med       Date:  2019-03-22       Impact factor: 0.982

7.  Bovine serum promotes the formation and phenotype memory retention of persister cells in Escherichia coli liquid cultures.

Authors:  Erika Suzuki; Tomoka Urushidani; Sumio Maeda
Journal:  World J Microbiol Biotechnol       Date:  2021-06-01       Impact factor: 3.312

8.  Innate immune evasion of Escherichia coli clinical strains from orthopedic implant infections.

Authors:  L Crémet; A Broquet; C Jacqueline; C Chaillou; K Asehnoune; S Corvec; N Caroff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-02       Impact factor: 3.267

9.  Serine protease autotransporters of Enterobacteriaceae (SPATEs) are largely distributed among Escherichia coli isolated from the bloodstream.

Authors:  Claudia A Freire; Ana Carolina M Santos; Antonio C Pignatari; Rosa M Silva; Waldir P Elias
Journal:  Braz J Microbiol       Date:  2020-01-21       Impact factor: 2.476

10.  Development and Qualification of an Opsonophagocytic Killing Assay To Assess Immunogenicity of a Bioconjugated Escherichia coli Vaccine.

Authors:  Darren Abbanat; Todd A Davies; Karen Amsler; Wenping He; Kellen Fae; Sarah Janssen; Jan T Poolman; Germie P J M van den Dobbelsteen
Journal:  Clin Vaccine Immunol       Date:  2017-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.